Aberrant allele-switch imprinting of a novel IGF1R intragenic antisense non-coding RNA in breast cancers

European Journal of Cancer

Volumn 51, Issue 2, 2015, Pages 260-270

  Kang, Lihua ^a   Sun, Jingnan ^a,b   Wen, Xue ^a   Cui, Jiuwei ^a   Wang, Guanjun ^a   Hoffman, Andrew R ^b   Hu, Ji Fan ^a,b   Li, Wei ^a  

^a JILIN UNIVERSITY   (China)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allelic expression; Breast cancer; DNA methylation; Gene regulation; Genomic imprinting; IGF1R; IRAIN; Non coding RNA

Indexed keywords

COMPLEMENTARY DNA; GENOMIC DNA; LONG UNTRANSLATED RNA; SOMATOMEDIN C; COMPLEMENTARY RNA; SOMATOMEDIN C RECEPTOR;

ALLELE; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOME IMPRINTING; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ADULT; AGED; BREAST TUMOR; GENE EXPRESSION REGULATION; GENETICS; MCF 7 CELL LINE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR CELL LINE;

ADULT; AGED; ALLELES; BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMIC IMPRINTING; GENOTYPE; HUMANS; MCF-7 CELLS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTOR, IGF TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, ANTISENSE; RNA, LONG NONCODING;

EID: 84925394534     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.10.031     Document Type: Article

References (71)

1. D.J. Blackman, and C.M. Masi Racial and ethnic disparities in breast cancer mortality: are we doing enough to address the root causes? J Clin Oncol 24 14 2006 2170 2178
2. N. Harbeck, M.W. Beckmann, A. Rody, A. Schneeweiss, V. Muller, and T. Fehm HER2 dimerization inhibitor pertuzumab - mode of action and clinical data in breast cancer Breast Care (Basel) 8 1 2013 49 55
3. D.J. Slamon, B. Leyland-Jones, S. Shak, H. Fuchs, V. Paton, and A. Bajamonde Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 344 11 2001 783 792
4. M. Barok, H. Joensuu, and J. Isola Trastuzumab emtansine: mechanisms of action and drug resistance Breast Cancer Res 13 2 2014 R46
5. R. Nahta, D. Yu, M.C. Hung, G.N. Hortobagyi, and F.J. Esteva Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer Nat Clin Pract Oncol 3 5 2006 269 280
6. S.V. Sharma, D.Y. Lee, B. Li, M.P. Quinlan, F. Takahashi, and S. Maheswaran A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations Cell 141 1 2010 69 80
7. N.L. Ge, and S. Rudikoff Insulin-like growth factor I is a dual effector of multiple myeloma cell growth Blood 96 8 2000 2856 2861
8. A.C. Sprynski, D. Hose, L. Caillot, T. Reme, J.D. Shaughnessy Jr., and B. Barlogie The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor Blood 113 19 2009 4614 4626
9. A.C. Sprynski, D. Hose, A. Kassambara, L. Vincent, M. Jourdan, and J.F. Rossi Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation Leukemia 24 11 2010 1940 1950
10. E. Seccareccia, and P. Brodt The role of the insulin-like growth factor-I receptor in malignancy: an update Growth Horm IGF Res 22 6 2012 193 199
11. M. Pollak The insulin and insulin-like growth factor receptor family in neoplasia: an update Nat Rev Cancer 12 3 2012 159 169
12. E.E. Ozkan Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: a review Mol Cell Endocrinol 344 1-2 2011 1 24
13. E. Capoluongo Insulin-like growth factor system and sporadic malignant melanoma Am J Pathol 178 1 2011 26 31
14. E.J. Gallagher, and D. LeRoith The proliferating role of insulin and insulin-like growth factors in cancer Trends Endocrinol Metab 21 10 2010 610 618
15. N. Chapuis, J. Tamburini, P. Cornillet-Lefebvre, L. Gillot, V. Bardet, and L. Willems Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody Haematologica 95 3 2010 415 423
16. V.L. Grandage, R.E. Gale, D.C. Linch, and A. Khwaja PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Map kinase and p53 pathways Leukemia 19 4 2005 586 594
17. Q. Xu, S.E. Simpson, T.J. Scialla, A. Bagg, and M. Carroll Survival of acute myeloid leukemia cells requires PI3 kinase activation Blood 102 3 2003 972 980
18. M.V. Karamouzis, and A.G. Papavassiliou Targeting insulin-like growth factor in breast cancer therapeutics Crit Rev Oncol Hematol 84 1 2012 8 17
19. C.E. Tognon, and P.H. Sorensen Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy Expert Opin Ther Targets 16 1 2012 33 48
20. E.K. Rowinsky, J.D. Schwartz, N. Zojwalla, H. Youssoufian, F. Fox, and P. Pultar Blockade of insulin-like growth factor type-1 receptor with cixutumumab (IMC-A12): a novel approach to treatment for multiple cancers Curr Drug Targets 12 14 2011 2016 2033
21. E. Buck, and M. Mulvihill Small molecule inhibitors of the IGF-1R/IR axis for the treatment of cancer Expert Opin Invest Drugs 20 5 2011 605 621
22. I. Heidegger, A. Pircher, H. Klocker, and P. Massoner Targeting the insulin-like growth factor network in cancer therapy Cancer Biol Ther 11 8 2011 701 707
23. R.A. Jones, C.I. Campbell, G.A. Wood, J.J. Petrik, and R.A. Moorehead Reversibility and recurrence of IGF-IR-induced mammary tumors Oncogene 28 21 2009 2152 2162
24. P. Moreau, F. Cavallo, X. Leleu, C. Hulin, M. Amiot, and G. Descamps Phase I study of the anti insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, AVE1642, as single agent and in combination with bortezomib in patients with relapsed multiple myeloma Leukemia 25 5 2011 872 874
25. H. Zhang, M.J. Zeitz, H. Wang, B. Niu, S. Ge, and W. Li Long noncoding RNA-mediated intrachromosomal interactions promote imprinting at the Kcnq1 locus J Cell Biol 204 1 2014 61 75
26. J. Sun, W. Li, Y. Sun, D. Yu, X. Wen, and H. Wang A novel antisense long noncoding RNA within the IGF1R gene locus is imprinted in hematopoietic malignancies Nucleic Acids Res 42 15 2014 9588 9601
27. H. Wang, W. Li, R. Guo, J. Sun, J. Cui, and G. Wang An intragenic long noncoding RNA interacts epigenetically with the RUNX1 promoter and enhancer chromatin DNA in hematopoietic malignancies Int J Cancer 135 12 2014 2783 2794
28. T. Li, H. Chen, W. Li, J. Cui, G. Wang, and X. Hu Promoter histone H3K27 methylation in the control of IGF2 imprinting in human tumor cell lines Hum Mol Genet 23 2014 117 128
29. J.F. Hu, T.H. Vu, and A.R. Hoffman Promoter-specific modulation of insulin-like growth factor II genomic imprinting by inhibitors of DNA methylation J Biol Chem 271 30 1996 18253 18262
30. S. Zhang, B. Zhong, M. Chen, G. Yang, Y. Li, and H. Wang Epigenetic reprogramming reverses the malignant epigenotype of the MMP/TIMP axis genes in tumor cells Int J Cancer 134 7 2014 1583 1594
31. R. Stoger, P. Kubicka, C.G. Liu, T. Kafri, A. Razin, and H. Cedar Maternal-specific methylation of the imprinted mouse Igf2r locus identifies the expressed locus as carrying the imprinting signal Cell 73 1 1993 61 71
32. A. Wutz, O.W. Smrzka, N. Schweifer, K. Schellander, E.F. Wagner, and D.P. Barlow Imprinted expression of the Igf2r gene depends on an intronic CpG island Nature 389 6652 1997 745 749
33. J.F. Hu, K.A. Balaguru, R.D. Ivaturi, H. Oruganti, T. Li, and B.T. Nguyen Lack of reciprocal genomic imprinting of sense and antisense RNA of mouse insulin-like growth factor II receptor in the central nervous system Biochem Biophys Res Commun 257 2 1999 604 608
34. J.F. Hu, J. Pham, I. Dey, T. Li, T.H. Vu, and A.R. Hoffman Allele-specific histone acetylation accompanies genomic imprinting of the insulin-like growth factor II receptor gene Endocrinology 141 12 2000 4428 4435
35. H. Cui, M. Cruz-Correa, F.M. Giardiello, D.F. Hutcheon, D.R. Kafonek, and S. Brandenburg Loss of IGF2 imprinting: a potential marker of colorectal cancer risk Science 299 5613 2003 1753 1755
36. T. Moore, M. Constancia, M. Zubair, B. Bailleul, R. Feil, and H. Sasaki Multiple imprinted sense and antisense transcripts, differential methylation and tandem repeats in a putative imprinting control region upstream of mouse Igf2 Proc Natl Acad Sci USA 94 23 1997 12509 12514
37. M.J. Sullivan, T. Taniguchi, A. Jhee, N. Kerr, and A.E. Reeve Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation Oncogene 18 52 1999 7527 7534
38. H. Cui, P. Onyango, S. Brandenburg, Y. Wu, C.L. Hsieh, and A.P. Feinberg Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2 Cancer Res 62 22 2002 6442 6446
39. H.L. Chen, T. Li, X.W. Qiu, J. Wu, J.Q. Ling, and Z.H. Sun Correction of aberrant imprinting of IGF2 in human tumors by nuclear transfer-induced epigenetic reprogramming EMBO J 25 22 2006 5329 5338
40. T. Li, J.F. Hu, X. Qiu, J. Ling, H. Chen, and S. Wang CTCF regulates allelic expression of Igf2 by orchestrating a promoter-polycomb repressive complex-2 intrachromosomal loop Mol Cell Biol 28 20 2008 6473 6482
41. D.A. Skaar, Y. Li, A.J. Bernal, C. Hoyo, S.K. Murphy, and R.L. Jirtle The human imprintome: regulatory mechanisms, methods of ascertainment, and roles in disease susceptibility ILAR J 53 3-4 2012 341 358
42. E.S. Polson, J.L. Lewis, H. Celik, V.M. Mann, M.J. Stower, and M.S. Simms Monoallelic expression of TMPRSS2/ERG in prostate cancer stem cells Nat Commun 4 2013 1623
43. A.A. Gimelbrant, A.W. Ensminger, P. Qi, J. Zucker, and A. Chess Monoallelic expression and asynchronous replication of p120 catenin in mouse and human cells J Biol Chem 280 2 2005 1354 1359
44. S. Esumi, N. Kakazu, Y. Taguchi, T. Hirayama, A. Sasaki, and T. Hirabayashi Monoallelic yet combinatorial expression of variable exons of the protocadherin-alpha gene cluster in single neurons Nat Genet 37 2 2005 171 176
45. A. Magklara, A. Yen, B.M. Colquitt, E.J. Clowney, W. Allen, and E. Markenscoff-Papadimitriou An epigenetic signature for monoallelic olfactory receptor expression Cell 145 4 2011 555 570
46. D. Roppolo, S. Vollery, C.D. Kan, C. Luscher, M.C. Broillet, and I. Rodriguez Gene cluster lock after pheromone receptor gene choice EMBO J 26 14 2007 3423 3430
47. K.L. Rhoades, N. Singh, I. Simon, B. Glidden, H. Cedar, and A. Chess Allele-specific expression patterns of interleukin-2 and Pax-5 revealed by a sensitive single-cell RT-PCR analysis Curr Biol 10 13 2000 789 792
48. M. Lin, A. Hrabovsky, E. Pedrosa, T. Wang, D. Zheng, and H.M. Lachman Allele-biased expression in differentiating human neurons: implications for neuropsychiatric disorders PLoS One 7 8 2012 e44017
49. E. Bonora, C. Graziano, F. Minopoli, E. Bacchelli, P. Magini, and C. Diquigiovanni Maternally inherited genetic variants of CADPS2 are present in autism spectrum disorders and intellectual disability patients EMBO Mol Med 6 2014 [Epub ahead of print]
50. E. Kopsida, M.A. Mikaelsson, and W. Davies The role of imprinted genes in mediating susceptibility to neuropsychiatric disorders Horm Behav 59 3 2011 375 382
51. A.P. Feinberg, and B. Tycko The history of cancer epigenetics Nat Rev Cancer 4 2 2004 143 153
52. T.M. Holm, L. Jackson-Grusby, T. Brambrink, Y. Yamada, W.M. Rideout 3rd, and R. Jaenisch Global loss of imprinting leads to widespread tumorigenesis in adult mice Cancer Cell 8 4 2005 275 285
53. H. Soejima, and K. Higashimoto Epigenetic and genetic alterations of the imprinting disorder Beckwith-Wiedemann syndrome and related disorders J Hum Genet 58 7 2013 402 409
54. O. Ogawa, M.R. Eccles, J. Szeto, L.A. McNoe, K. Yun, and M.A. Maw Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour Nature 362 6422 1993 749 751
55. S. Rainier, L.A. Johnson, C.J. Dobry, A.J. Ping, P.E. Grundy, and A.P. Feinberg Relaxation of imprinted genes in human cancer Nature 362 6422 1993 747 749
56. A.P. Feinberg Genomic imprinting and gene activation in cancer Nat Genet 4 2 1993 110 113
57. G.S. Randhawa, H. Cui, J.A. Barletta, L.Z. Strichman-Almashanu, M. Talpaz, and H. Kantarjian Loss of imprinting in disease progression in chronic myelogenous leukemia Blood 91 9 1998 3144 3147
58. L. Zhang, W. Zhou, V.E. Velculescu, S.E. Kern, R.H. Hruban, and S.R. Hamilton Gene expression profiles in normal and cancer cells Science 276 5316 1997 1268 1272
59. T. Sohda, K. Iwata, H. Soejima, S. Kamimura, H. Shijo, and K. Yun In situ detection of insulin-like growth factor II (IGF2) and H19 gene expression in hepatocellular carcinoma J Hum Genet 43 1 1998 49 53
60. S. Takeda, M. Kondo, T. Kumada, T. Koshikawa, R. Ueda, and M. Nishio Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease Oncogene 12 7 1996 1589 1592
61. G.A. Ulaner, T.H. Vu, T. Li, J.F. Hu, X.M. Yao, and Y. Yang Loss of imprinting of Igf2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site Hum Mol Genet 12 5 2003 535 549
62. W.K. Hofmann, S. Takeuchi, M.A. Frantzen, D. Hoelzer, and H.P. Koeffler Loss of genomic imprinting of insulin-like growth factor 2 is strongly associated with cellular proliferation in normal hematopoietic cells Exp Hematol 30 4 2002 318 323
63. L. Cong, F.A. Ran, D. Cox, S. Lin, R. Barretto, and N. Habib Multiplex genome engineering using CRISPR/Cas systems Science 339 6121 2013 819 823
64. P. Mali, L. Yang, K.M. Esvelt, J. Aach, M. Guell, and J.E. DiCarlo RNA-guided human genome engineering via Cas9 Science 339 6121 2013 823 826
65. D.P. Barlow, R. Stoger, B.G. Hermann, K. Saito, and N. Schweifer The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus Nature 349 1991 84 87
66. D.P. Barlow Gametic imprinting in mammals Science 270 5242 1995 1610 1613
67. D.P. Barlow Competition - a common motif for the imprinting mechanism? EMBO J 16 23 1997 6899 6905
68. J.F. Hu, H. Oruganti, T.H. Vu, and A.R. Hoffman Tissue-specific imprinting of the mouse insulin-like growth factor II receptor gene correlates with differential allele-specific DNA methylation Mol Endocrinol 12 2 1998 220 232
69. A. Wutz, and D.P. Barlow Imprinting of the mouse Igf2r gene depends on an intronic CpG island Mol Cell Endocrinol 140 1-2 1998 9 14
70. T.K. Howard, E.M. Algar, J.A. Glatz, A.E. Reeve, and P.J. Smith The insulin-like growth factor 1 receptor gene is normally biallelically expressed in human juvenile tissue and tumours Hum Mol Genet 2 12 1993 2089 2092
71. O. Ogawa, L.A. McNoe, M.R. Eccles, I.M. Morison, and A.E. Reeve Human insulin-like growth factor type I and type II receptors are not imprinted Hum Mol Genet 2 12 1993 2163 2165